Constantin N. Baxevanis

Prof. Constantin N. Baxevanis

St Savvas Cancer Hospital
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2019 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
MSMichail Sofopoulos
Michail Sofopoulos
SFSotirios P. Fortis
Sotirios P. Fortis
CVChristoforos K. Vaxevanis
Christoforos K. Vaxevanis
NSNectaria N. Sotiriadou
Nectaria N. Sotiriadou
NANiki Arnogiannaki
Niki Arnogiannaki
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis

1 July 2021 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis
SFSotirios P. Fortis
Sotirios P. Fortis
SPSonia A. Perez
Sonia A. Perez

15 August 2008 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis
SPSonia A. Perez
Sonia A. Perez
MPMichael Papamichail
Michael Papamichail

18 April 2017 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
SFSotirios P. Fortis
Sotirios P. Fortis
MSMichail Sofopoulos
Michail Sofopoulos
NSNectaria N. Sotiriadou
Nectaria N. Sotiriadou
CHChristoforos Haritos
Christoforos Haritos
CVChristoforos K. Vaxevanis
Christoforos K. Vaxevanis
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis
Background Tumor immune cell infiltrates are essential in hindering cancer progression and may complement the TNM classification. CD8+ and CD163+ cells have prognostic impact in breast cancer but their spatial heterogeneity has not been extensively explored in this type of cancer. Here, their potential as prognostic biomarkers was evaluated, depending on their combined densities in the tumor center (TC) and the tumor invasive margin (IM). Methods CD8+ and CD163+ cells were quantified by immunohistochemistry of formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples from a cohort totaling 162 patients with histologically-confirmed primary invasive non-metastatic ductal breast cancer diagnosed between 2000 and 2015. Clinical follow-up (median 6.9 years) was available for 97 of these patients. Results Differential densities of CD8+ and CD163+ cells in the combined TC and IM compartments (i.e., high(H)/low(L), respectively for CD8+ cells and the reverse L/H combination for CD163+ cells) were found to have significant prognostic value for survival, and allowed better patient stratification than TNM stage, tumor size, lymph node invasion and histological grade. The combined evaluation of CD8+ and CD163+ cell densities jointly in TC and IM further improves prediction of clinical outcomes based on disease-free and overall survival. Patients having the favorable immune signatures had favorable clinical outcomes despite poor clinicopathological parameters. Conclusions Given the important roles of CD8+ and CD163+ cells in regulating opposing immune circuits, adding an assessment of their differential densities to the prognostic biomarker armamentarium in breast cancer would be valuable. Larger validation studies are necessary to confirm these findings. Trial registrations Study code: IRB-ID 6079/448/10-6-13 Date of approval: 10/06/2013 Retrospective study (2000–2010) First patient prospectively enrolled 14/2/2014

20 April 2010 in Cancer
Verified
Journal Article
Closed access
PDF file
SPSonia A. Perez
Sonia A. Perez
EHEric von Hofe
Eric von Hofe
NKNikoletta L. Kallinteris
Nikoletta L. Kallinteris
AGAngelos D. Gritzapis
Angelos D. Gritzapis
GPGeorge E. Peoples
George E. Peoples
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis

27 October 2005 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
Constantin N. BaxevanisConstantin N. Baxevanis
Constantin N. Baxevanis
NSNectaria N. Sotiriadou
Nectaria N. Sotiriadou
AGAngelos D. Gritzapis
Angelos D. Gritzapis
PSPanagiota A. Sotiropoulou
Panagiota A. Sotiropoulou
SPSonia A. Perez
Sonia A. Perez
MPMichael Papamichail
Michael Papamichail